|
Volumn 44, Issue 10, 2012, Pages 1074-1075
|
Bringing the genomic landscape of small-cell lung cancer into focus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
CRIZOTINIB;
ERLOTINIB;
ETOPOSIDE;
FIBROBLAST GROWTH FACTOR RECEPTOR 1;
GEFITINIB;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
TOPOTECAN;
TRANSCRIPTION FACTOR SOX2;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER SURVIVAL;
CANCER TISSUE;
CYTOLOGY;
FGFR1 GENE;
FUSION GENE;
GENE AMPLIFICATION;
GENE MUTATION;
GENETIC HETEROGENEITY;
GENETIC MARKER;
GENOME;
GENOME ANALYSIS;
HUMAN;
INOPERABLE CANCER;
LUNG ADENOCARCINOMA;
LUNG BIOPSY;
LUNG NON SMALL CELL CANCER;
LUNG SQUAMOUS CELL CARCINOMA;
MUTATIONAL ANALYSIS;
MYCL1 GENE;
ONCOGENE;
ONCOGENE C MYC;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RECURRENT CANCER;
RLF MYCL1 FUSION GENE;
SOX2 GENE;
TUMOR BIOPSY;
ANIMALS;
GENE AMPLIFICATION;
GENOME, HUMAN;
HUMANS;
LUNG NEOPLASMS;
SMALL CELL LUNG CARCINOMA;
SOXB1 TRANSCRIPTION FACTORS;
|
EID: 84866857282
PISSN: 10614036
EISSN: 15461718
Source Type: Journal
DOI: 10.1038/ng.2415 Document Type: Article |
Times cited : (37)
|
References (15)
|